신세포암 동물모델에서 전신적 면역치료와 동반한 국소 냉동요법의 항암 효과 = Antitumor Effect of in Situ Cryoablation with Systemic Immunotherapy on Murine Renal Cell Tumor

다국어 초록 (Multilingual Abstract)

Purpose: To investigate synergistic effect of local cryoablation with systemic immunotherapy, the tumor control ability and immunologic responses of combining these two modalities was compared with that of cryoablation, surgical excision, and immunotherapy only group in a tumor re-challenge model.
Materials and Methods: Preliminary experiments were performed in two stages. The first stage consisted of 36 Balb/c mice with Renca bearing tumors imbedded in the right thigh, and was treated with interleukin-2 (IL-2) and interferon-alpha(IFN-α) to evaluate the efficacy of immunotherapy and to determine the adequate dosage. The second stage was performed on 10 mice, to evaluate histological changes and efficacy after cryoablation. The main experiment was performed on 48 mice, divided into 6 groups of control with tumor implantation, excision of tumor, excision combined with immunotherapy, cryoablation of tumor, cryoablation with immunotherapy and control without tumor. After treatment, tumor re-challenge was performed with Renca cell, then the growth pattern was evaluated with physical measurements, and immune response was investigated with fluorescent activated cell sorter and cytotoxicity assay.
Results: Preliminary studies on immunologic efficacy revealed that IL-2 and IFN-α have a dose dependent inhibition of tumor growth. The main experiment evaluating the efficacy of combination treatment revealed that cryoablation with immunotherapy proved to be most effective in terms of tumor recurrence and tumor growth inhibition, yet the difference was not statistically significant from monotherapy with cryoablation. However, cytotoxicity was significantly increased cryoablation with immunotherapy compared with other groups.
Conclusions: Cryoablation on tumor re-challenge mice model showed advantages with immunotherapy most prominently in cytotoxicity.

다국어 초록 (Multilingual Abstract)

Purpose: To investigate synergistic effect of local cryoablation with systemic immunotherapy, the tumor control ability and immunologic responses of combining these two modalities was compared with that of cryoablation, surgical excision, and immunotherapy only group in a tumor re-challenge model.
Materials and Methods: Preliminary experiments were performed in two stages. The first stage consisted of 36 Balb/c mice with Renca bearing tumors imbedded in the right thigh, and was treated with interleukin-2 (IL-2) and interferon-alpha(IFN-α) to evaluate the efficacy of immunotherapy and to determine the adequate dosage. The second stage was performed on 10 mice, to evaluate histological changes and efficacy after cryoablation. The main experiment was performed on 48 mice, divided into 6 groups of control with tumor implantation, excision of tumor, excision combined with immunotherapy, cryoablation of tumor, cryoablation with immunotherapy and control without tumor. After treatment, tumor re-challenge was performed with Renca cell, then the growth pattern was evaluated with physical measurements, and immune response was investigated with fluorescent activated cell sorter and cytotoxicity assay.
Results: Preliminary studies on immunologic efficacy revealed that IL-2 and IFN-α have a dose dependent inhibition of tumor growth. The main experiment evaluating the efficacy of combination treatment revealed that cryoablation with immunotherapy proved to be most effective in terms of tumor recurrence and tumor growth inhibition, yet the difference was not statistically significant from monotherapy with cryoablation. However, cytotoxicity was significantly increased cryoablation with immunotherapy compared with other groups.
Conclusions: Cryoablation on tumor re-challenge mice model showed advantages with immunotherapy most prominently in cytotoxicity.

참고문헌 (Reference)

1 Patard JJ, "Use of the University of California Los Angeles integrated staging system to predict survival in renal call carcinoma: an international multicenter study" 22 : 3316-22, 2004

2 Kang SH, "The development of tumour- specific immunity induced by cryosurgery in murine renal cell carcinoma animal model" 5 : 29-, 2006

3 Jacobs SC, "Synchronous bilateral renal cell carcinoma: total surgical excision" 2341-5, 1980

4 Campbell SC, "Renal tumors. ;In:Campbell's urology. 9th ed" Saunders 1567-637, 2007

5 Colimbu M, "Renal cell carcinoma: survival and prognostic factors" 27 : 291-301, 1986

6 Fergany AF, "Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow up" 163 : 442-5, 2000

7 Moll V, "Kidney preserving surgery in renal cell tumors: indications, techniques and results in 152 patients" 150 : 319-23, 1993

8 Hafez KS, "Indication and limitations of cytoreductive nephrectomy for metastatic renal cell carcinoma" 31 : 2004

9 Sabel MS, "In-situ ablation of breast cancer" 12 : 131-40, 2001

10 Johnson JP, "Immunologic aspects of cryosurgery: potential modulation of immune recognition and effector cell maturation" 8 : 39-47, 1990

11 Belldegrun A, "Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system" 17 : 2868-75, 1999

12 Flanigan RC, "Debulking nephrectomy in metastatic renal cancer" 10 : S6335-41, 2004

13 Kaouk JH, "Cryotherapy: clinical end points and their experimental foundations" 68 (68): 38-44, 2006

14 Suzuki Y, "Cryosurgical treatment of advanced breast cancer and cryoimmunological responses" 10 : 19-26, 1995

15 Gage AA, "Cryosurgical ablation of the prostate" 5 : 19-24, 2000

16 Ablin RJ, "Cryosurgery of the monkey(macaque) prostate. I. Humoral immunologic responsiveness following cryostimulation" 13 : 47-53, 1976

17 Fujikawa S, "Continuous observation of frozen biological materials with cryo-scanning electron microscope and freeze-replica by a new cryo-system" 37 : 315-322, 1988

18 Hruby G, "Comparison of laparoscopic partial nephrectomy and laparoscopic cryoablation for renal hilar tumors" 67 : 50-4, 2006

19 Airoldi M, "Combined chemotherapy, cryosurgery, and radiotherapy/surgery for oral cancer" 5 : 357-62, 1985

20 Hornung RL, "Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2" 141 : 3671-9, 1988

21 Sayers TJ, "Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer(Renca) in vitro and in vivo" 52 : 5414-20, 1990

22 Ablin RJ, "An appreciation and realization of the concept of cryoimmunology ; In Percutaneous prostate cryoablation. 1st ed" St. Louis: Quality Medical Publishing 136-54, 1995

23 Sabel M, "Adoptive immunotherapy of breat cancer with lymph node cells primed by cryoablation of the primary tumor" 53 : 360-6, 2006

24 O'Malley RL, "A matched-cohort comparison of laparoscopic cryoablation and laparoscopic partial nephrectomy for treating renal masses" 99 : 395-8, 2007